Interrupting HIV Treatment Could Be Beneficial
Main Category: HIV / AIDSAlso Included In: Compliance
Article Date: 07 Aug 2006 - 18:00 PDT
| Patient / Public: | ![]() |
4.5 (2 votes) |
| Healthcare Prof: | ![]() |
4.5 (2 votes) |
Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment, according to an article in The Lancet.
Though extremely effective at preventing AIDS, lifelong treatment with Highly Active Anti-Retroviral Therapy (HAART) is expensive and can lead to serious side effects, such as liver damage. Decreasing the time that patients receive HAART could solve these problems but interrupting therapy may increase the risk of the disease progressing. The virus may also become resistant to HAART if treatment stops and low concentrations of the drug remain in the body.
Bernard Hirschel (University Hospital of Geneva, Switzerland) and colleagues assessed whether taking scheduled breaks in HAART was as effective as giving patients treatment on a continuous basis. 430 patients with chronic HIV were either placed in a scheduled interruption group (284), where treatment was temporarily stopped depending on their immune response, or in a group where HAART was given continuously (146) for 22 months. The results showed that levels of resistance and control of the HIV virus were similar between the two groups. Certain side effects such as diarrhoea and nausea were also less frequent in this group, while minor manifestations of HIV, such as oral thrush, were more common.
Dr Hirschel concludes: 'The results provide reassurance about the one risk that was feared - development of resistance and loss of efficacy of treatment...Scheduled treatment interruptions lasting many months, with substantial drug savings, can be anticipated, particularly in patients whose immune systems were never damaged by HIV.
###
Contact:
B. Hirschel, Division des maladies infectieuses
HCUG, CH-1211 Genčve.
bernard.hirschel@hcuge.ch
Contact: Joe Santangelo
Lancet
Visit our hiv / aids section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/48823.php>
APA
http://www.medicalnewstoday.com/releases/48823.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



